HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA Would ‘Overstep’ Authority With Planned OTC Sunscreen Environmental Impact Statement

Executive Summary

The Public Access to Sunscreens Coalition suggests the FDA should stay in its regulatory lane or at least await the results of a National Academies of Sciences study before moving forward with an environmental impact statement to the US Environmental Protection Agency regarding certain UV filters under GRASE review reported to harm marine coral.

You may also be interested in...

PASS Hangs Hopes On NAS Study To Stop Maui’s Non-Mineral Sunscreen Ban

A spokesperson for the sunscreen advocacy group is hopeful that a National Academies of Sciences study on the way will convince Maui County not to ban non-chemical sunscreens as planned in October. At the same time, “We’re very concerned that there are members of the Maui County Council that would prefer to just ban everything rather than wait for the science,” she said.

Hawaii Lawmakers Will Rethink Larger Ban On Sunscreen Ingredients

Environmental groups and local policymakers joined industry in opposing HB 1519, which would ban UV filters in Hawaii that are not characterized as GRASE by the US Food and Drug Administration as of 1 January 2023. In their view, that has the potential to undo existing bans on oxybenzone and octinoxate.

Hawaii Considers Sweeping Ban On ‘Chemical’ UV Filters, Taking Cues From US FDA

Following Maui County’s example, Hawaii state lawmakers seem intent on limiting OTC sunscreen sales to products formulated with zinc oxide and titanium dioxide, the only active ingredients upheld as GRASE by the US FDA in recent rulemaking overtures.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts